Euro approval for the World's largest animal health business22 October 2007
EUROPE - Schering-Plough Corporation has received European Commission approval for its planned acquisition of Organon BioSciences, from Akzo Nobel.
As part of the deal Schering-Plough also acquires Nobilon, the human vaccine development unit, and Diosynth, a third-party manufacturing unit of Organon. No divestitures are required in this sector of the business.
The acquisition is almost finalised, bar certain regulatory approvals, including clearance from the US Federal Trade Commission, which are currently underway.
||- Go to our previous news item on this story by clicking here.|
TheFishSite News Desk